Education
About Us
Working with TipRanks
Follow Us
Altria (GB:0R31)
:0R31
Earnings Data
Report Date
Jul 30, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
1.38Last Year’s EPS
1.31Same Quarter Last Year
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Date:Apr 29, 2025
|% Change Since: 2.69%
|Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While Altria showcased growth in the oral nicotine pouch category and maintained strong performance in smokeable products, challenges in the e-vapor market and declines in cigarette volumes presented significant concerns. Economic pressures on consumers also suggest potential headwinds.Company Guidance
During the Altria Group, Inc. 2025 First Quarter Earnings Conference Call, management provided guidance for the fiscal year 2025, projecting a full-year adjusted diluted EPS range of $5.30 to $5.45, reflecting a growth rate of 2% to 5% from a base of $5.19 in 2024. The company highlighted its focus on maintaining strong cash returns through dividends and share repurchases, with $674 million remaining under the current share repurchase program. Altria also emphasized robust net price realization in the smokeable products segment, achieving a 10.8% increase, despite a 12% adjusted decline in domestic cigarette volumes. In the oral tobacco products segment, the nicotine pouch ON! showed significant growth, with a reported shipment volume increase of 18%, expanding its market share to 8.8% of the oral tobacco category. The call also addressed challenges in the e-vapor category, including the impact of illicit products, and detailed Altria's strategic focus on regulatory engagements and product innovation to navigate the evolving market landscape.Growth in Oral Nicotine Pouches
The oral nicotine pouch category saw an estimated 10% increase in industry volume over the past six months. In the first quarter, ON! grew its reported shipment volume by 18%, expanding its share of the oral tobacco category to 8.8%.
Strong Performance of Smokeable Products
The smokeable products segment grew adjusted operating company's income by 2.7%, supported by a robust net price realization of 10.8%.
Shareholder Returns
Altria paid approximately $1.7 billion in dividends and repurchased 5.7 million shares for $326 million in the first quarter.
Marlboro's Resilient Performance
Marlboro expanded its share of the premium segment by 0.1 share point to 59.3%, maintaining its leadership in the category despite economic pressures.
GB:0R31 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GB:0R31 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 29, 2025 | $57.99 | $58.68 | +1.19% |
Jan 30, 2025 | $51.72 | $50.33 | -2.69% |
Oct 31, 2024 | $48.69 | $52.64 | +8.11% |
Jul 31, 2024 | $47.89 | $46.12 | -3.69% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Altria (GB:0R31) report earnings?
Altria (GB:0R31) is schdueled to report earning on Jul 30, 2025, TBA Not Confirmed.
What is Altria (GB:0R31) earnings time?
Altria (GB:0R31) earnings time is at Jul 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Altria stock?
The P/E ratio of Altria Group is N/A.
What is GB:0R31 EPS forecast?
GB:0R31 EPS forecast for the fiscal quarter 2025 (Q2) is 1.38.
